Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cemex S.A.B. de C.V. Sponsored ADR (CX) vs Hims and Hers Health Inc (HIMS) Price & Performance

Cemex S.A.B. de C.V. Sponsored ADRTrade
Hims and Hers Health IncTrade

Price performance (Past 24H)

Key statistics

Cemex S.A.B. de C.V. Sponsored ADR vs Hims and Hers Health Inc — how do they compare? Cemex S.A.B. de C.V. Sponsored ADR trades at $9.56 (market cap $13.84B), while Hims and Hers Health Inc trades at $28.4 (market cap $6.89B). The key difference: Cemex S.A.B. de C.V. Sponsored ADR is far larger — about 2× Hims and Hers Health Inc's market cap, and Cemex S.A.B. de C.V. Sponsored ADR pays a 1.3% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cemex S.A.B. de C.V. Sponsored ADR for 0 Days and Hims and Hers Health Inc for 21 Days on average.

CXHIMS
Market Cap
$13.84B$6.89B
Volume
6,589,7145,446,628
Sector
Basic MaterialsHealth
52-Week High
$13.55$62.76
52-Week Low
$9.12$14.52
Typical Hold Time
0 Days21 Days
Enterprise Value
$19.83B$7.60B
Dividend Yield
1.3%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cemex S.A.B. de C.V. Sponsored ADR

No Aura AI signal available yet.

Hims and Hers Health Inc

Hims & Hers Health trades at $29.54, up 0.24% on the day, with a bullish technical signal from moving averages but mixed earnings performance. Revenue grew to $2.35 billion in 2025, yet the company posted a net loss of $142 million in 2026, reflecting profitability challenges. High valuation ratios like a P/E of 57.14 and negative ROE of -32.03% indicate premium pricing despite weak earnings. Recent news highlights multiple securities class action lawsuits filed in October 2026, creating legal overhangs.

The stock faces headwinds from profitability struggles and legal risks, but analyst consensus remains a Buy with a $32.17 price target, suggesting modest upside. Investment appeal hinges on resolving operational inefficiencies and legal issues to align valuation with fundamentals, while current sentiment is cautious due to recent earnings misses and regulatory scrutiny.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CX
100% Buy0% Sell
Avg holding period · 0 Days
HIMS
86% Buy14% Sell
Avg holding period · 21 Days

About Cemex S.A.B. de C.V. Sponsored ADR

Cemex produces, distributes, markets, and sells cement, ready-mix concrete, aggregates, and other construction materials. Its operations serve markets around the world.

Read more on CX →

About Hims and Hers Health Inc

Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.

Read more on HIMS →